IMAP partners in Spain and Germany advise Atrys on the acquisition of Swiss firm Radio-Onkologie Amsler AG
Atrys is a Spanish biomedical company dedicated to providing diagnostic services and medical treatments primarily for oncology patients
The two long-term shareholders of GELSENCHEM Chemical Products GmbH, Miguel Fábrega and Thomas Lüllemann, have sold all their shares to Höppner Finanz Holding, a company owned by Dr. Nils-Oliver Höppner and Mr. Rüdiger Funke. Given their previous activities in the chemical industry, the two new shareholders will bring new expertise to the company. This will enable GELSENCHEM to build up a new business segment and to expand their offering beyond the current product portfolio.
GELSENCHEM is a leading distributor of methanol and specialty chemicals in Germany and Benelux. The company’s customers include manufacturers of biofuels as well as operators of wastewater treatment and industrial plants. As Germany's largest methanol distributor in the segment of tank truck deliveries, GELSENCHEM has successfully positioned itself in the market as an independent company.
The IMAP team consisting of Karl Fesenmeyer, Christoph Gluschke, Ulrich Keesen and Luis Frey exclusively advised and supported the shareholders of GELSENCHEM Chemical Products GmbH in all phases of the M&A process.
Atrys is a Spanish biomedical company dedicated to providing diagnostic services and medical treatments primarily for oncology patients
Founder and CEO Ragip Aydin will keep a significant stake in Raynet
WhitePress is a leading content marketing platform that assists advertising agencies and corporate clients in the creation and publication of high-quality content across the web, as well as tracking marketing campaign results